Artesunate

Artesunate is a medicine used to treat malaria. It's a type of artemisinin, which is a natural compound found in plants. It works by killing the malaria parasite in your body. It's often used in combination with other medicines to make it more effective.

Medication

What people taking Artesunate report

Every report comes from a Lived member, sent anonymously.

Have you tried Artesunate for Malaria?

NameHow it went

About Artesunate

What It's For

Artesunate is an antimalarial medicine, a semi-synthetic (partly lab-made) form of a compound called artemisinin. In the United States it is given into a vein (intravenously) in the hospital as the first treatment for severe malaria, a rare but life-threatening form of the infection seen mostly in travelers returning from areas where malaria is common. It is approved for both adults and children, and it is now the standard of care for severe malaria in the US. The US product is sold simply as Artesunate for Injection. In many other countries, artesunate is also taken by mouth as part of an artemisinin-based combination therapy (ACT), which pairs it with a second antimalarial such as amodiaquine, mefloquine or pyronaridine to treat uncomplicated malaria. Those oral combinations are not approved in the US. Researchers have also studied artesunate against other infections, such as cytomegalovirus, and against some cancers, but those uses remain experimental.

How It Works

Malaria is caused by Plasmodium parasites that multiply inside red blood cells. Once in the bloodstream, artesunate is rapidly converted into its main active form, dihydroartemisinin (DHA). Both molecules contain a reactive oxygen bridge that is triggered by iron in heme, the iron-carrying part of the blood, and this releases highly reactive molecules that damage the parasites and stop them from growing. Artesunate acts fast: it typically clears parasites from the blood within two to three days. It does not reach every stage of every malaria species. Plasmodium vivax and Plasmodium ovale can leave dormant forms in the liver that artesunate does not kill, which is why some people need an additional medicine afterward.

Dosage & Administration

Artesunate is given by a nurse or doctor in the hospital as a slow injection into a vein over one to two minutes. The dose is based on body weight and is the same per kilogram for adults and children, including young infants. Doses are given at the start, at 12 hours and at 24 hours, then once a day until the person is well enough to swallow tablets. Many people need only a few doses. Artesunate is only the first part of treatment. It must always be followed by a complete course of an antimalarial taken by mouth, which kills remaining parasites and keeps the infection from returning. Finishing that full course after leaving the hospital matters even when you already feel better.

Side Effects

Severe malaria itself can damage the kidneys, break down red blood cells and cause yellowing of the skin, so it is often hard to separate the illness from the medicine. In the main trials, the problems seen most often during treatment were kidney failure needing dialysis, dark urine from released hemoglobin and jaundice, each at rates close to those seen with the older treatment, quinine. Less serious effects reported in other studies include headache, dizziness, nausea, vomiting, abdominal pain, a changed sense of taste, ringing in the ears, cough and rash. The side effect people most need to know about appears after they go home. In some people, red blood cells that were infected break down a week or more after treatment started, causing anemia (a low red blood cell count). This is called post-artesunate delayed hemolysis. It is usually manageable, but some people have needed a blood transfusion. Regular blood tests for four weeks after treatment are recommended to catch it early. Contact your care team promptly if you notice dark urine, yellowing of the skin or eyes, or new tiredness or shortness of breath during those weeks.

Interactions & Warnings

Artesunate should not be given to anyone who has had a serious allergic reaction, such as anaphylaxis, to it before. Allergic reactions are uncommon and usually begin while the medicine is being given in the hospital. Trouble breathing, hives or a widespread rash, or feeling faint during or soon after a dose needs immediate medical care; the team can stop artesunate and switch to another antimalarial. If the malaria is caused by Plasmodium vivax or Plasmodium ovale, artesunate alone will not prevent the infection from coming back weeks or months later. A second medicine from the 8-aminoquinoline group, such as primaquine, is needed to clear the dormant liver forms and prevent relapse. Some medicines can lower artesunate's effect, including the HIV medicines ritonavir and nevirapine, the tuberculosis antibiotic rifampin and the seizure medicines carbamazepine and phenytoin. If they are used together, the team watches more closely to confirm the malaria is responding. Animal studies raised concerns about harm to a developing baby, but decades of experience with artemisinin-type medicines in pregnant women have not shown a clear increase in birth defects or miscarriage. Untreated severe malaria is very dangerous for both mother and baby, so treatment should not be delayed because of pregnancy. Tell the team if you are or might be pregnant.

What to Expect

Artesunate is given in the hospital while the team treats the other effects of severe malaria. Blood tests are repeated to confirm that the number of parasites is falling. Once you can eat and drink and swallow tablets, the IV doses stop and the oral antimalarial course begins. In large trials, artesunate prevented more deaths from severe malaria than quinine, the older standard, in both adults and children. Even so, recovery depends on how ill a person was before treatment, and some people need care for kidney, lung or brain complications. Children treated with artesunate had slightly more neurologic problems at discharge than those given quinine, though most of these faded over time. After discharge, plan for blood tests over the next four weeks to check for delayed anemia, and finish every dose of the oral medicine you are given.

Questions to Ask Your Doctor

  1. 1.Which type of malaria do I have, and do I need an extra medicine afterward to prevent it from coming back?
  2. 2.Which oral medicine will I take after artesunate, and for how long?
  3. 3.When and where should I have blood tests over the next four weeks, and what results would concern you?
  4. 4.Do any of my current medicines, such as HIV, tuberculosis or seizure medicines, affect how well artesunate works?
  5. 5.How should I protect myself against malaria if I travel to an area where it is common again?

Last reviewed • Oct 2026

Educational content, not medical advice.